Allogene Therapeutics, Inc. ALLO · Insights

website

151

Allogene Therapeutics, Inc. operates as a clinical-stage immuno-oncology firm dedicated to the creat...

Price1.06

Market Cap367.26 M

Float328.38 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Key Dates & Timelines

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro

Financial Transactions

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro